159 related articles for article (PubMed ID: 29287007)
21. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
22. Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study.
van Atteveld JE; de Winter DTC; Pluimakers VG; Fiocco M; Nievelstein RAJ; Hobbelink MGG; de Vries ACH; Loonen JJ; van Dulmen-den Broeder E; van der Pal HJ; Pluijm SMF; Kremer LCM; Ronckers CM; van der Heiden-van der Loo M; Versluijs AB; Louwerens M; Bresters D; van Santen HM; Olsson DS; Hoefer I; van den Berg SAA; den Hartogh J; Tissing WJE; Neggers SJCMM; van den Heuvel-Eibrink MM;
Lancet Diabetes Endocrinol; 2023 Jan; 11(1):21-32. PubMed ID: 36513116
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density in the long term after liver transplantation.
Hamburg SM; Piers DA; van den Berg AP; Slooff MJ; Haagsma EB
Osteoporos Int; 2000; 11(7):600-6. PubMed ID: 11069194
[TBL] [Abstract][Full Text] [Related]
24. Bone density in post-pubertal adolescent survivors of childhood brain tumors.
Cohen LE; Gordon JH; Popovsky EY; Sainath NN; Feldman HA; Kieran MW; Gordon CM
Pediatr Blood Cancer; 2012 Jun; 58(6):959-63. PubMed ID: 22431246
[TBL] [Abstract][Full Text] [Related]
25. A long-term trajectory of bone mineral density in childhood cancer survivors after discontinuation of treatment: retrospective cohort study.
Latoch E; Konstantynowicz J; Krawczuk-Rybak M; Panasiuk A; Muszyńska-Rosłan K
Arch Osteoporos; 2021 Feb; 16(1):45. PubMed ID: 33635381
[TBL] [Abstract][Full Text] [Related]
26. Risk factors and surveillance for reduced bone mineral density in pediatric cancer survivors.
Siegel DA; Claridy M; Mertens A; George E; Vangile K; Simoneaux SF; Meacham LR; Wasilewski-Masker K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28233475
[TBL] [Abstract][Full Text] [Related]
27. Preterm birth does not affect bone mineral density in young adults.
Breukhoven PE; Leunissen RW; de Kort SW; Willemsen RH; Hokken-Koelega AC
Eur J Endocrinol; 2011 Jan; 164(1):133-8. PubMed ID: 21030495
[TBL] [Abstract][Full Text] [Related]
28. Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).
Kaste SC; Qi A; Smith K; Surprise H; Lovorn E; Boyett J; Ferry RJ; Relling MV; Shurtleff SA; Pui CH; Carbone L; Hudson MM; Ness KK
Pediatr Blood Cancer; 2014 May; 61(5):885-93. PubMed ID: 24395288
[TBL] [Abstract][Full Text] [Related]
29. Relationships of Bone Mineral Density to Whole Body Mass, Fat Mass and Fat-free Mass in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood.
Athale UH; Marriott CJC; Cranston A; McDonald P; Webber CE; Farncombe TH; Barr RD
J Pediatr Hematol Oncol; 2021 Jan; 43(1):12-17. PubMed ID: 32675554
[TBL] [Abstract][Full Text] [Related]
30. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study.
van der Sluis IM; Boot AM; Hop WC; De Rijke YB; Krenning EP; de Muinck Keizer-Schrama SM
Horm Res; 2002; 58(5):207-14. PubMed ID: 12401939
[TBL] [Abstract][Full Text] [Related]
32. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
33. Comparison of phalangeal ultrasound and dual energy X-ray absorptiometry in healthy male and female adolescents.
Halaba ZP; Konstantynowicz J; Pluskiewicz W; Kaczmarski M; Piotrowska-Jastrzebska J
Ultrasound Med Biol; 2005 Dec; 31(12):1617-22. PubMed ID: 16344124
[TBL] [Abstract][Full Text] [Related]
34. Long-term effect of childhood liver transplantation on body cell mass.
Ee LC; Hill RJ; Beale K; Noble C; Fawcett J; Cleghorn GJ
Liver Transpl; 2014 Aug; 20(8):922-9. PubMed ID: 24753196
[TBL] [Abstract][Full Text] [Related]
35. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
[TBL] [Abstract][Full Text] [Related]
36. Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation.
Tauchmanovà L; Serio B; Del Puente A; Risitano AM; Esposito A; De Rosa G; Lombardi G; Colao A; Rotoli B; Selleri C
J Clin Endocrinol Metab; 2002 Nov; 87(11):5058-65. PubMed ID: 12414872
[TBL] [Abstract][Full Text] [Related]
37. Peak bone mineral density, lean body mass and fractures.
Boot AM; de Ridder MA; van der Sluis IM; van Slobbe I; Krenning EP; Keizer-Schrama SM
Bone; 2010 Feb; 46(2):336-41. PubMed ID: 19833245
[TBL] [Abstract][Full Text] [Related]
38. Bone loss after orthotopic liver transplantation.
Meys E; Fontanges E; Fourcade N; Thomasson A; Pouyet M; Delmas PD
Am J Med; 1994 Nov; 97(5):445-50. PubMed ID: 7977433
[TBL] [Abstract][Full Text] [Related]
39. Z-score comparability of bone mineral density reference databases for children.
Kocks J; Ward K; Mughal Z; Moncayo R; Adams J; Högler W
J Clin Endocrinol Metab; 2010 Oct; 95(10):4652-9. PubMed ID: 20668038
[TBL] [Abstract][Full Text] [Related]
40. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
